Parkinson’s disease is a progressive neurological disorder characterized by tremors, rigidity, and bradykinesia, which gradually impair movement and coordination over time. recoveriX includes for Parkinson’s patients 24 therapy sessions, along with pre- and post-assessments. Here present an example of a female patients, who performed the following tests:
In the two pre-assessments, the TUG time was around 27 seconds. The patient showed a significant improvement, eventually reaching approximately 13 seconds, which corresponds to a percentage improvement of 52%.

The 10MWT for self-selected velocity (SSV) was around 13 seconds before recoveriX treatment, and the patient quickly improved with the recoveriX treatment. By the end, the patient needed about 7 seconds, again reflecting a substantial improvement of 44%. Similarly, also the patient’s fast velocity (FV) 10MWT improved by 33%.

The BBT and 9HPT show improvements in both gross- and fine motor function in the patient’s respective hands.


The patient reported after the recoveriX treatment that she is able to play darts with very high precision and that she has improved in archery. Currently the clinical study is ongoing.
Also have a look at our before and after videos, where you can see the improvements, stroke, multiple sclerosis etc. patients, made with the help of recoveriX!
Woytowicz, E. J., Rietschel, J. C., Goodman, R. N., Conroy, S. S., Sorkin, J. D., Whitall, J., & McCombe Waller, S. (2017). Determining levels of upper extremity movement impairment by applying a cluster analysis to the Fugl-Meyer assessment of the upper extremity in chronic stroke. Archives of Physical Medicine and Rehabilitation, 98(3), 456–462. doi:10.1016/j.apmr.2016.06.023
Page, S. J., Fulk, G. D., & Boyne, P. (2012). Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Physical Therapy, 92(6), 791–798. doi:10.2522/ptj.20110009
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information